Skip to search.
 TSX Up 0.34% TSX Ventures Up 0.11%

XOMA Corporation (XOMA)

-NasdaqGM
3.70 0.00(0.00%) Apr 20, 4:00PM EDT
|After Hours : 3.70 0.00 (0.00%) Apr 20, 5:23PM EDT
Add to Portfolio
Prev Close:3.70
Open:3.71
Bid:3.65 x 3000
Ask:3.87 x 500
1y Target Est:8.71
Beta:3.54
Earnings Date:May 4 - May 10 (Est.)
Day's Range:3.61 - 3.78
52wk Range:3.22 - 5.95
Volume:1,413,844
Avg Vol (3m):2,191,000
Market Cap:429.88M
P/E (ttm):N/A
EPS (ttm):-0.68
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
XOMA 0.00%429.88M
NVS 0.00%245.24B
REGNUp 1.09%46.09B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):22.79
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-0.59
Quarterly EPS Est (Mar-15) :-0.16
Mean Recommendation*:1.8
PEG Ratio (5 yr expected):-0.34

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

XOMA Corporation discovers and develops antibody-based therapeutics in the United States, Europe, and the Asia Pacific. The company’s lead product candidate includes gevokizumab, a proprietary humanized allosteric-modulating monoclonal antibo... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback